Search

Omid Veiseh

age ~45

from Bellaire, TX

Also known as:
  • Omid Vei

Omid Veiseh Phones & Addresses

  • Bellaire, TX
  • Cambridge, MA
  • 11628 NE 100Th St, Kirkland, WA 98033
  • 124 33Rd St, Bellingham, WA 98225
  • 1705 Maple, Bellingham, WA 98226 • 3607380845
  • 10914 81St Pl NE, Kirkland, WA 98034

Work

  • Company:
    Sigilon therapeutics, inc.
    Feb 2016 to Sep 2017
  • Position:
    Founding scientist and head of innovation

Education

  • School / High School:
    Massachusetts Institute of Technology
    2011 to 2016
  • Specialities:
    Chemical Engineering

Skills

Biomaterials • Nanotechnology • Nanoparticles • Cell • Drug Delivery • Cell Culture • Tissue Engineering • Cancer • Fluorescence Microscopy • Nanomaterials • Microscopy • Molecular Biology • Cell Biology • Materials Science • Biochemistry • Biosensors • Flow Cytometry • Fluorescence • Western Blotting • Protein Purification • Scanning Electron Microscopy • Elisa • Immunohistochemistry • Tissue Culture • Protein Expression • Cancer Research • Electron Microscopy • Immunology • Stem Cells • Protein Chemistry • Molecular Cloning • Sirna • Polymers • Bioconjugate Chemistry • Fluorescence Spectroscopy • Assay Development • In Vivo • In Vitro • Gene Therapy • Molecular Imaging • Bioengineering • Animal Models • Transfection • Microfluidics • Diabetes • Mri • Brain Tumors • Fibrosis • Biophysics

Languages

English • Persian

Interests

Science and Technology • Education • Health

Industries

Biotechnology
Name / Title
Company / Classification
Phones & Addresses
Omid Veiseh
Partner
Omid Veiseh
Child Day Care Services
11628 NE 100 St, Kirkland, WA 98033
4255769211

Amazon

This Is Not Available 043242

This is not available 043242

view source

This book is not available.


Author
Omid Veiseh

Binding
Paperback

Pages
218

Publisher
ProQuest, UMI Dissertation Publishing

ISBN #
1244098639

EAN Code
9781244098633

ISBN #
1

Us Patents

  • Fluorescent Chlorotoxin Conjugate And Method For Intra-Operative Visualization Of Cancer

    view source
  • US Patent:
    20080279780, Nov 13, 2008
  • Filed:
    Aug 31, 2007
  • Appl. No.:
    11/897721
  • Inventors:
    Miqin Zhang - Bothell WA, US
    Richard G. Ellenbogen - Seattle WA, US
    Raymond W. Sze - Mclean VA, US
    Omid Veiseh - Kirkland WA, US
    James M. Olson - Seattle WA, US
    Mandana Veiseh - Emeryville CA, US
    Patrick Gabikian - Seattle WA, US
  • Assignee:
    Washington, University of - Seattle WA
    Fred Hutchinson Cancer Research Center - Seattle WA
  • International Classification:
    A61K 49/00
  • US Classification:
    424 96
  • Abstract:
    A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.
  • Nanoparticles For Brain Tumor Imaging

    view source
  • US Patent:
    20100260686, Oct 14, 2010
  • Filed:
    Apr 9, 2009
  • Appl. No.:
    12/384923
  • Inventors:
    Miqin Zhang - Bothell WA, US
    Conroy Sun - Kirkland WA, US
    Omid Veiseh - Kirkland WA, US
    Narayan Bhattarai - Seattle WA, US
  • Assignee:
    Washington, University of - Seattle WA
  • International Classification:
    A61K 49/18
    A61K 49/00
    A61K 9/16
    G01N 33/567
  • US Classification:
    424 9322, 424 91, 424 93, 424493, 435 721
  • Abstract:
    Nanoparticle having a chitosan-polyethylene oxide oligomer copolymer coating, and methods for making and using the nanoparticle are provided. The nanoparticle can have a core that includes a material that imparts magnetic resonance imaging activity to the particle and, optionally, one or more of an associated targeting agent, fluorescent agent, or therapeutic agent.
  • Polyarginine-Coated Magnetic Nanovector And Methods Of Use Thereof

    view source
  • US Patent:
    20130302252, Nov 14, 2013
  • Filed:
    May 13, 2013
  • Appl. No.:
    13/893137
  • Inventors:
    Omid Veiseh - Kirkland WA, US
    Chen Fang - Lynnwood WA, US
    Forrest Kievit - Brier WA, US
  • International Classification:
    A61K 47/34
    A61K 9/50
  • US Classification:
    424 93, 424497, 514 44 R, 514 44 A, 424 96, 435 71, 435375
  • Abstract:
    Polyarginine-coated nanoparticle, and methods for making and using the nanoparticle. The nanoparticle can have a core that includes a material that imparts magnetic resonance imaging activity to the particle and, optionally, include one or more of an associated therapeutic agent, targeting agent, and diagnostic agent.
  • Chlorotoxin-Labeled Nanoparticle Compositions And Methods For Targeting Primary Brain Tumors

    view source
  • US Patent:
    20070154965, Jul 5, 2007
  • Filed:
    Nov 14, 2006
  • Appl. No.:
    11/600004
  • Inventors:
    Miqin Zhang - Bothell WA, US
    James Olson - Seattle WA, US
    Raymond Sze - Mercer Island WA, US
    Richard Ellenbogen - Seattle WA, US
    Omid Veiseh - Kirkland WA, US
    Conroy Sun - Kirkland WA, US
    Jonathan Gunn - Seattle WA, US
  • International Classification:
    G01N 33/574
  • US Classification:
    435007230, 435455000, 977902000
  • Abstract:
    Chlorotoxin-labeled nanoparticles that target primary brain tumors, compositions that include the nanoparticles, methods of imaging tissues using the nanoparticles, and methods for treating tissues using the nanoparticles.
  • Compositions, Devices, And Methods For Treating Fabry Disease

    view source
  • US Patent:
    20220267794, Aug 25, 2022
  • Filed:
    Mar 27, 2020
  • Appl. No.:
    17/598176
  • Inventors:
    - Cambridge MA, US
    Michael Beauregard - Boston MA, US
    Guillaume Carmona - Cambridge MA, US
    Francisco Caballero Gonzalez - Brookline MA, US
    Richard Heidebrecht - Somerville MA, US
    Erika Ellen Johnston - Cambridge MA, US
    Robert James Miller - East Bridgewater MA, US
    Owen O'Connor - Raynham MA, US
    Matthias Alexander Oberli - Cambridge MA, US
    David Peritt - Skokie IL, US
    Jared A. Sewell - Somerville MA, US
    Devyn McKinley Smith - Barrington RI, US
    Omid Veiseh - Bellaire TX, US
    Jeffrey Charles Way - Cambridge MA, US
    Paul Kevin Wotton - Boston MA, US
    Zoe Yin - Boston MA, US
    Elina Makino - Winchester MA, US
    Brian Richard Fluharty - Boston MA, US
    Marianthi Papakosta - Cambridge MA, US
  • International Classification:
    C12N 15/85
    A61K 38/47
    A61K 47/22
    A61K 9/50
    C08L 5/04
  • Abstract:
    Described herein are RPE cells engineered to secrete a GLA protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating Fabry disease.
  • High Throughput Genetic Barcoding And Analysis Methods

    view source
  • US Patent:
    20230054899, Feb 23, 2023
  • Filed:
    Jan 14, 2021
  • Appl. No.:
    17/758828
  • Inventors:
    - Houston TX, US
    Ping SONG - Houston TX, US
    Omid VEISEH - Houston TX, US
    Siavash PARKHIDEH - Houston TX, US
    Sudip MUKHERJEE - Houston TX, US
    Maria Isabel RUOCCO - Houston TX, US
    Boram KIM - Houston TX, US
    Yuxuan CHENG - Houston TX, US
  • Assignee:
    William Marsh Rice University - Houston TX
  • International Classification:
    C12N 5/00
    C12N 15/10
    A61K 49/00
    A61K 9/50
    A61K 35/39
  • Abstract:
    Provided herein are high-throughput methods for genetic barcoding and analysis, e.g., for tagging each biomaterial apsule with a barcode cell. These barcode cells are derived from patient samples, and thus embody natural human genetic variation. Also provided are SNP panels that can be used as genetic barcodes to identify the identity of a cell.
  • Implantable Particles And Related Methods

    view source
  • US Patent:
    20210145759, May 20, 2021
  • Filed:
    Mar 27, 2019
  • Appl. No.:
    17/045127
  • Inventors:
    - Cambridge MA, US
    Michael Beauregard - Boston MA, US
    Guillaume Carmona - Cambridge MA, US
    Francisco Caballero Gonzalez - Brookline MA, US
    Richard Heidebrecht - Somerville MA, US
    Erika Ellen Johnston - Cambridge MA, US
    Robert James Miller - East Bridgewater MA, US
    Matthias Alexander Oberli - Cambridge MA, US
    Owen O'Connor - Raynham MA, US
    David Peritt - Skokie IL, US
    Jared A. Sewell - Somerville MA, US
    Devyn McKinley Smith - Barrington RI, US
    Omid Veiseh - Bellaire TX, US
    Paul Kevin Wotton - Boston MA, US
  • International Classification:
    A61K 9/50
    A61K 35/28
    A61K 35/30
    C07K 14/755
    C07K 14/62
    C12N 9/64
  • Abstract:
    Described herein are particles comprising a first compartment, a second compartment, and a compound of Formula (I), as well as compositions and methods of making and using the same. The particles may comprise a cell capable of expressing a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.
  • Methods, Compositions, And Implantable Elements Comprising Stem Cells

    view source
  • US Patent:
    20210145889, May 20, 2021
  • Filed:
    Mar 27, 2019
  • Appl. No.:
    17/045137
  • Inventors:
    - Cambridge MA, US
    David Peritt - Skokie IL, US
    Omid Veiseh - Bellaire TX, US
    Richard Heidebrecht - Somerville MA, US
    Robert James Miller - East Bridgewater MA, US
  • International Classification:
    A61K 35/28
    A61K 9/00
    A61K 47/22
    A61K 9/50
    A61L 27/38
    A61K 38/37
    A61K 38/48
    C12N 5/00
    A61K 38/28
    C12N 5/0775
  • Abstract:
    Described herein are cell compositions comprising a mesenchymal stem function cell (MSFC), e.g., an engineered MSFC or derivatives thereof, as well as compositions, pharmaceutical products, and implantable elements comprising an MSFC, and methods of making and using the same. The cells and compositions may express a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.

Resumes

Omid Veiseh Photo 1

Co-Founder

view source
Location:
Cambridge, MA
Industry:
Biotechnology
Work:
Sigilon Therapeutics, Inc. Feb 2016 - Sep 2017
Founding Scientist and Head of Innovation

Rice University Feb 2016 - Sep 2017
Assistant Professor and Cprit Scholar In Cancer Research Department of Bioengineering

Boston Children's Hospital Nov 2011 - May 2016
Research Fellow

Massachusetts Institute of Technology (Mit) Nov 2011 - May 2016
Postdoctoral Research Fellow

Sigilon Therapeutics, Inc. Nov 2011 - May 2016
Co-Founder
Education:
Massachusetts Institute of Technology 2011 - 2016
University of Washington 2005 - 2009
Doctorates, Doctor of Philosophy, Engineering, Materials Science, Nanotechnology
Western Washington University 1997 - 2002
Bachelors, Bachelor of Science, Biology
Skills:
Biomaterials
Nanotechnology
Nanoparticles
Cell
Drug Delivery
Cell Culture
Tissue Engineering
Cancer
Fluorescence Microscopy
Nanomaterials
Microscopy
Molecular Biology
Cell Biology
Materials Science
Biochemistry
Biosensors
Flow Cytometry
Fluorescence
Western Blotting
Protein Purification
Scanning Electron Microscopy
Elisa
Immunohistochemistry
Tissue Culture
Protein Expression
Cancer Research
Electron Microscopy
Immunology
Stem Cells
Protein Chemistry
Molecular Cloning
Sirna
Polymers
Bioconjugate Chemistry
Fluorescence Spectroscopy
Assay Development
In Vivo
In Vitro
Gene Therapy
Molecular Imaging
Bioengineering
Animal Models
Transfection
Microfluidics
Diabetes
Mri
Brain Tumors
Fibrosis
Biophysics
Interests:
Science and Technology
Education
Health
Languages:
English
Persian

Youtube

Bioengineers at Rice tackle ovarian and color...

Rice University Bioengineer Omid Veiseh and colleagues created tiny im...

  • Duration:
    3m 52s

Study shows how breast implants affect immune...

A new study, co-authored by a Rice University professor, looks at how ...

  • Duration:
    4m 39s

Drug Factory Implants in Ovarian Cancer: Lear...

Speaker: Dr. Omid Veiseh, Professor, Rice University.

  • Duration:
    10m 14s

OTT Technology Spotlight Season 1 Episode 3: ...

The Veiseh laboratory utilizes advanced nano, micro, and macro fabrica...

  • Duration:
    2m

Drug Factory Implants Successfully Cure Certa...

Here's a pic of Rice University bioengineer Omid Veiseh with a vial of...

  • Duration:
    6m 43s

Sushi Implant - 2013 Image Award Winner

Omid Veiseh, Joshua Doloff, Minglin Ma, Alan Chiu, and Arturo Vegas ex...

  • Duration:
    3m 55s

Masters of Disguise: 2015 Image Award winner

Andrew Bader, Omid Veiseh, and Arturo Vegas share the story of stealth...

  • Duration:
    3m 20s

Innovation in Medicine to address COVID-19

"Innovation in Medicine to address COVID-19 by Dr. Omid Veiseh, Ph.D.

  • Duration:
    34m 3s

Googleplus

Omid Veiseh Photo 2

Omid Veiseh

Work:
Massachusetts Institute of Technology - Postdoctoral Research Fellow (2011)

News

Feds Fund $45M Rice-Led Research That Could Slash Us Cancer Deaths By 50%

Feds fund $45M Rice-led research that could slash US cancer deaths by 50%

view source
  • Instead of tethering patients to hospital beds, IV bags and external monitors, well use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time, said Rice bioengineer Omid Veiseh, principal investigator (Pedu/news/files/2023/09/0925_THOR-ajov222bm-lg2k.jpg CAPTION: Omid Veiseh (right) and Amir Jazaeri in Veisehs Rice University laboratory in August 2023. Veiseh is principal investigator on the targeted hybrid oncotherapeutic regulation (THOR) project, a $45 million program that the Advanced Rese
  • Date: Sep 26, 2023
  • Category: Health
  • Source: Google
Local Scientists Worry About Nih's Proposed Cap On Funding For Individual Labs

Local scientists worry about NIH's proposed cap on funding for individual labs

view source
  • The sentiment makes a lot of sense, said Omid Veiseh, a former postdoctoral researcher in the Langer Lab who was recently hired as an assistant professor in the bioengineering department at Rice University in Houston, where he hopes to set up a lab. Junior faculty members, the people starting lab
  • Date: Jun 07, 2017
  • Category: Health
  • Source: Google
Encapsulated Pancreatic Cells Offer New Diabetes Treatment

Encapsulated pancreatic cells offer new diabetes treatment

view source
  • "The exciting part of this was being able to show, in an immune-competent mouse, that when encapsulated these cells do survive for a long period of time, at least six months," noted Omid Veiseh, a senior post-doc at the Koch Institute and Boston Children's hospital.
  • Date: Jan 26, 2016
  • Category: Health
  • Source: Google
No More Insulin Injections? Encapsulated Pancreatic Cells Offer Possible New Diabetes Treatment

No more insulin injections? Encapsulated pancreatic cells offer possible new diabetes treatment

view source
  • "The really exciting part of this was being able to show, in an immune-competent mouse, that when encapsulated these cells do survive for a long period of time, at least six months," says Omid Veiseh, a senior postdoc at the Koch Institute and Boston Children's hospital and co-first author of the Na
  • Date: Jan 25, 2016
  • Category: Health
  • Source: Google

Other Social Networks

Omid Veiseh Photo 3

omid veiseh Google+

view source
Network:
GooglePlus
18 Aug 2011 omid veiseh has not filled out his profile yet. ... omid veiseh is using Google+. Join Google+ to connect with the people who matter most.

Get Report for Omid Veiseh from Bellaire, TX, age ~45
Control profile